Carbapenem-resistant Pseudomonas aeruginosa carrying bla

Animals Anti-Bacterial Agents / pharmacology Bacterial Typing Techniques Carbapenems / pharmacology DNA, Bacterial / genetics Disease Models, Animal Larva / microbiology Microbial Sensitivity Tests Moths / microbiology Multilocus Sequence Typing Pseudomonas Infections Pseudomonas aeruginosa / classification Virulence beta-Lactamases / genetics
Carbapenemase Metallo-β-lactamase Multidrug resistance Nosocomial infection Pseudomonas aeruginosa bla(VIM-36)

Journal

Journal of global antimicrobial resistance
ISSN: 2213-7173
Titre abrégé: J Glob Antimicrob Resist
Pays: Netherlands
ID NLM: 101622459

Informations de publication

Date de publication:
03 2019
Historique:
received: 09 03 2018
revised: 23 08 2018
accepted: 06 09 2018
pubmed: 24 9 2018
medline: 26 3 2020
entrez: 24 9 2018
Statut: ppublish

Résumé

Based on pulsed-field gel electrophoresis (PFGE) profile, whole-genome sequencing (WGS) of eight carbapenem-resistant Pseudomonas aeruginosa isolates from a bone marrow transplant unit in São Paulo, Brazil, was performed to investigate the presence of resistance and virulence genes as well as to determine the sequence type (ST) by multilocus sequence typing (MLST). The initial phenotypic susceptibility pattern of the isolates was determined by VITEK WGS demonstrated that mutations in genes encoding outer membrane proteins and efflux pumps in an isolate harbouring bla P. aeruginosa carrying bla

Identifiants

DOI: 10.1016/j.jgar.2018.09.007 PMID: 30244038
pubmed: 30244038
pii: S2213-7165(18)30180-2
doi: 10.1016/j.jgar.2018.09.007
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Carbapenems 0
DNA, Bacterial 0
beta-Lactamases EC 3.5.2.6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

92-97

Informations de copyright

Copyright © 2018 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.

Auteurs

Patrícia R Neves (PR)

Department of Infectious Diseases and LIM-54, Institute of Tropical Medicine of São Paulo, University of São Paulo, São Paulo, Brazil.

Lauro Vieira Perdigão Neto (LV)

Department of Infection Control, Hospital das Clínicas, University of São Paulo, São Paulo, Brazil.

Roberta Cristina Ruedas Martins (RC)

Department of Infectious Diseases and LIM-54, Institute of Tropical Medicine of São Paulo, University of São Paulo, São Paulo, Brazil.

Jéssica F Ramos (JF)

Department of Infectious Diseases and LIM-54, Institute of Tropical Medicine of São Paulo, University of São Paulo, São Paulo, Brazil.

Gleice Leite (G)

Department of Infectious Diseases and LIM-54, Institute of Tropical Medicine of São Paulo, University of São Paulo, São Paulo, Brazil.

Flavia Rossi (F)

Laboratory of Microbiology, Hospital das Clínicas, University of São Paulo, São Paulo, Brazil.

Sabri Saeed Sanabani (SS)

Laboratory of Medical Investigation 56 (LIM-56), Institute of Tropical Medicine of São Paulo, University of São Paulo, São Paulo, Brazil.

Vanderson Rocha (V)

Bone Marrow Transplant Unit, Hospital das Clínicas, University of São Paulo, São Paulo, Brazil.

Marjorie Vieira Batista (MV)

Department of Infectious Diseases and LIM-54, Institute of Tropical Medicine of São Paulo, University of São Paulo, São Paulo, Brazil.

Thais Guimaraes (T)

Department of Infection Control, Hospital das Clínicas, University of São Paulo, São Paulo, Brazil.

Anna S Levin (AS)

Department of Infectious Diseases and LIM-54, Institute of Tropical Medicine of São Paulo, University of São Paulo, São Paulo, Brazil; Department of Infection Control, Hospital das Clínicas, University of São Paulo, São Paulo, Brazil.

Sílvia F Costa (SF)

Department of Infectious Diseases and LIM-54, Institute of Tropical Medicine of São Paulo, University of São Paulo, São Paulo, Brazil; Department of Infection Control, Hospital das Clínicas, University of São Paulo, São Paulo, Brazil. Electronic address: costasf@ig.com.br.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male

Evaluating the efficacy of telesurgery with dual console SSI Mantra Surgical Robotic System: experiment on animal model and clinical trials.

Sudhir Prem Srivastava, Vishwajyoti Pascual Srivastava, Avinesh Singh et al.
1.00
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell

FBXO22 inhibits colitis and colorectal carcinogenesis by regulating the degradation of the S2448-phosphorylated form of mTOR.

Minle Li, Xuan Chen, Pengfei Qu et al.
1.00
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Carbapenem-resistant Pseudomonas aeruginosa...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › Carbapenem-resistant Pseudomonas aeruginosa...
questionsmedicales.fr › Techniques d'investigation › Techniques de laboratoire clinique › Techniques microbiologiques › Techniques bactériologiques › Techniques de typage bactérien › Carbapenem-resistant Pseudomonas aeruginosa...
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › bêta-Lactames › Carbapénèmes › Carbapenem-resistant Pseudomonas aeruginosa...
questionsmedicales.fr › Acides nucléiques, nucléotides et nucléosides › Acides nucléiques › ADN › ADN bactérien › Carbapenem-resistant Pseudomonas aeruginosa...
questionsmedicales.fr › Techniques d'investigation › Modèles théoriques › Modèles biologiques › Modèles animaux de maladie humaine › Carbapenem-resistant Pseudomonas aeruginosa...
questionsmedicales.fr › Phénomènes physiologiques › Croissance et développement › Morphogenèse › Métamorphose biologique › Étapes du cycle de vie › Larve › Carbapenem-resistant Pseudomonas aeruginosa...
questionsmedicales.fr › Techniques d'investigation › Évaluation préclinique de médicament › Tests de sensibilité microbienne › Carbapenem-resistant Pseudomonas aeruginosa...
questionsmedicales.fr › Eucaryotes › Animaux › Invertébrés › Arthropodes › Insectes › Pterygota › Neoptera › Holometabola › Lepidoptera › Papillons de nuit › Carbapenem-resistant Pseudomonas aeruginosa...
questionsmedicales.fr › Techniques d'investigation › Techniques génétiques › Analyse de séquence › Analyse de séquence d'ADN › Typage par séquençage multilocus › Carbapenem-resistant Pseudomonas aeruginosa...
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Infections bactériennes › Infections bactériennes à Gram négatif › Infections à Pseudomonas › Carbapenem-resistant Pseudomonas aeruginosa...
questionsmedicales.fr › Bactéries › Proteobacteria › Gammaproteobacteria › Pseudomonadaceae › Pseudomonas › Pseudomonas aeruginosa › Carbapenem-resistant Pseudomonas aeruginosa...
questionsmedicales.fr › Phénomènes microbiologiques › Virulence › Carbapenem-resistant Pseudomonas aeruginosa...
questionsmedicales.fr › Enzymes et coenzymes › Enzymes › Hydrolases › Amidohydrolases › bêta-Lactamases › Carbapenem-resistant Pseudomonas aeruginosa...